Effect of Apneic Oxygenation of the Non-ventilated Lung During Lung Cancer Surgery.

Recruiting now · Not applicable

Conditions studied: Lung Cancer (Diagnosis)

In brief

This study investigates the effect of apneic oxygenation of the non-ventilated lung on local and systemic inflammatory response during lung cancer surgery. Patients undergoing surgical resection of lung cancer often require one-lung ventilation during anaesthesia. This results in alveolar hypoxia accompanied by upregulated expression of inflammatory markers. Apneic oxygenation of the non-ventiladed lung may influence inflammatory processes and oxygenation during surgery. The aim of this study is to evaluate whether apneic oxygenation affects inflammatory markers in lung tissue and postoperative recovery in patients undergoing lung cancer surgery. The study is conducted at a single center and includes adult patients scheduled for elective lung cancer surgery. Data will be collected durig the perioperative period. The results of this study may contribute to improved anaesthetic management and patient outcomes during thoracic surgery.

Key facts

Study ID

NCT07393490

Run by

Osijek University Hospital

People needed

56

Starts

2025-01-02

Expected to finish

2026-09-01

Last updated by the study team

2026-06-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults aged 18 years or older
• Patients scheduled to undergo surgical resection of a single lung segment for lung cancer
• Written informed consent provided

You may not qualify if…

• Age younger than 18 years
• Chronic corticosteroid therapy and/or other immunomodulatory treatments
• Severe pulmonary diseases, including:
• Chronic obstructive pulmonary disease classified as GOLD stage 3-4 (Global Initiative for Chronic Obstructive Lung Disease).
• Severe asthma according to GINA classification (Global Initiative for Asthma), step 4.
• Severe interstitial lung disease defined by: Forced vital capacity (FVC) < 50% predicted, diffusing capacity of the lung for carbon monoxide (DLCO) < 40% predicted, presence of extensive pulmonary fibrosis on computed tomography (CT)
• Surgical procedure expected to last less than 2 hours
• Intraoperative hemodynamic instability, defined as: Mean arterial pressure < 60 mmHg for more than 30 minutes despite adequate volume resuscitation, requirement for high-dose vasopressor support (norepinephrine > 0.2 µg/kg/min)
• New-onset intraoperative cardiac arrhythmias
• Significant intraoperative blood loss, defined as the need for transfusion of more than two units of packed red blood cells
• Intraoperative ventilatory instability, defined as: Severe hypoxemia (PaO₂ < 60 mmHg or SpO₂ < 85% with FiO₂ 1.0), hypercapnia (PaCO₂ > 70 mmHg with pH < 7.2), inability to achieve adequate ventilation.

Where it is running

• University Hospital Center Osijek — Osijek, Croatia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.